Literature DB >> 34559996

NAD+ flux is maintained in aged mice despite lower tissue concentrations.

Melanie R McReynolds1, Karthikeyani Chellappa2, Eric Chiles3, Connor Jankowski4, Yihui Shen1, Li Chen1, Hélène C Descamps5, Sarmistha Mukherjee2, Yashaswini R Bhat2, Siddharth R Lingala2, Qingwei Chu2, Paul Botolin2, Faisal Hayat6, Tomohito Doke7, Katalin Susztak7, Christoph A Thaiss5, Wenyun Lu1, Marie E Migaud6, Xiaoyang Su3, Joshua D Rabinowitz8, Joseph A Baur9.   

Abstract

NAD+ is an essential coenzyme for all living cells. NAD+ concentrations decline with age, but whether this reflects impaired production or accelerated consumption remains unclear. We employed isotope tracing and mass spectrometry to probe age-related changes in NAD+ metabolism across tissues. In aged mice, we observed modest tissue NAD+ depletion (median decrease ∼30%). Circulating NAD+ precursors were not significantly changed, and isotope tracing showed the unimpaired synthesis of nicotinamide from tryptophan. In most tissues of aged mice, turnover of the smaller tissue NAD+ pool was modestly faster such that absolute NAD+ biosynthetic flux was maintained, consistent with more active NAD+-consuming enzymes. Calorie restriction partially mitigated age-associated NAD+ decline by decreasing consumption. Acute inflammatory stress induced by LPS decreased NAD+ by impairing synthesis in both young and aged mice. Thus, the decline in NAD+ with normal aging is relatively subtle and occurs despite maintained NAD+ production, likely due to increased consumption.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD38; NAD; NADH; PARP; PARP1; SIRT1; aging; flux; mononucleotide; niacin; nicotinamide; redox; riboside; sirtuins

Mesh:

Substances:

Year:  2021        PMID: 34559996      PMCID: PMC8678178          DOI: 10.1016/j.cels.2021.09.001

Source DB:  PubMed          Journal:  Cell Syst        ISSN: 2405-4712            Impact factor:   10.304


  77 in total

1.  Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.

Authors:  Kathryn F Mills; Shohei Yoshida; Liana R Stein; Alessia Grozio; Shunsuke Kubota; Yo Sasaki; Philip Redpath; Marie E Migaud; Rajendra S Apte; Koji Uchida; Jun Yoshino; Shin-Ichiro Imai
Journal:  Cell Metab       Date:  2016-10-27       Impact factor: 27.287

2.  CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism.

Authors:  Juliana Camacho-Pereira; Mariana G Tarragó; Claudia C S Chini; Veronica Nin; Carlos Escande; Gina M Warner; Amrutesh S Puranik; Renee A Schoon; Joel M Reid; Antonio Galina; Eduardo N Chini
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

3.  Deuterium isotope effects on initial rates of the liver alcohol dehydrogenase reaction.

Authors:  K Bush; V J Shiner; H R Mahler
Journal:  Biochemistry       Date:  1973-11-06       Impact factor: 3.162

4.  Nicotinamide Mononucleotide, an NAD+ Precursor, Rescues Age-Associated Susceptibility to AKI in a Sirtuin 1-Dependent Manner.

Authors:  Yi Guan; Su-Rong Wang; Xin-Zhong Huang; Qiong-Hong Xie; Yun-Yu Xu; Da Shang; Chuan-Ming Hao
Journal:  J Am Soc Nephrol       Date:  2017-02-28       Impact factor: 10.121

5.  Metabolite Spectral Accuracy on Orbitraps.

Authors:  Xiaoyang Su; Wenyun Lu; Joshua D Rabinowitz
Journal:  Anal Chem       Date:  2017-05-18       Impact factor: 6.986

Review 6.  NAD(+) metabolism: Bioenergetics, signaling and manipulation for therapy.

Authors:  Yue Yang; Anthony A Sauve
Journal:  Biochim Biophys Acta       Date:  2016-06-29

7.  Nicotinamide phosphoribosyltransferase is required for the calorie restriction-mediated improvements in oxidative stress, mitochondrial biogenesis, and metabolic adaptation.

Authors:  Jie Song; Sen-Fang Ke; Can-Can Zhou; Sai-Long Zhang; Yun-Feng Guan; Tian-Ying Xu; Chun-Quan Sheng; Pei Wang; Chao-Yu Miao
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-08-14       Impact factor: 6.053

8.  The Nuclear Receptor LXR Limits Bacterial Infection of Host Macrophages through a Mechanism that Impacts Cellular NAD Metabolism.

Authors:  Jonathan Matalonga; Estibaliz Glaria; Mariana Bresque; Carlos Escande; José María Carbó; Kerstin Kiefer; Ruben Vicente; Theresa E León; Susana Beceiro; Mónica Pascual-García; Joan Serret; Lucía Sanjurjo; Samantha Morón-Ros; Antoni Riera; Sonia Paytubi; Antonio Juarez; Fernando Sotillo; Lennart Lindbom; Carme Caelles; Maria-Rosa Sarrias; Jaime Sancho; Antonio Castrillo; Eduardo N Chini; Annabel F Valledor
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.995

9.  Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats.

Authors:  Nady Braidy; Gilles J Guillemin; Hussein Mansour; Tailoi Chan-Ling; Anne Poljak; Ross Grant
Journal:  PLoS One       Date:  2011-04-26       Impact factor: 3.240

10.  SLC25A51 is a mammalian mitochondrial NAD+ transporter.

Authors:  Timothy S Luongo; Jared M Eller; Mu-Jie Lu; Marc Niere; Fabio Raith; Caroline Perry; Marc R Bornstein; Paul Oliphint; Lin Wang; Melanie R McReynolds; Marie E Migaud; Joshua D Rabinowitz; F Brad Johnson; Kai Johnsson; Mathias Ziegler; Xiaolu A Cambronne; Joseph A Baur
Journal:  Nature       Date:  2020-09-09       Impact factor: 49.962

View more
  11 in total

Review 1.  The CD38 glycohydrolase and the NAD sink: implications for pathological conditions.

Authors:  Julianna D Zeidler; Kelly A Hogan; Guillermo Agorrody; Thais R Peclat; Sonu Kashyap; Karina S Kanamori; Lilian Sales Gomez; Delaram Z Mazdeh; Gina M Warner; Katie L Thompson; Claudia C S Chini; Eduardo Nunes Chini
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-09       Impact factor: 4.249

2.  Sexually dimorphic effects of SARM1 deletion on cardiac NAD+ metabolism and function.

Authors:  Hina Lateef Nizami; Keaton E Minor; Ying Ann Chiao; Christine M Light; Chi Fung Lee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-09-02       Impact factor: 5.125

Review 3.  Age-Dependent Decline of NAD+-Universal Truth or Confounded Consensus?

Authors:  Augusto Peluso; Mads V Damgaard; Marcelo A S Mori; Jonas T Treebak
Journal:  Nutrients       Date:  2021-12-27       Impact factor: 5.717

4.  Combining Metabolomics and Experimental Evolution Reveals Key Mechanisms Underlying Longevity Differences in Laboratory Evolved Drosophila melanogaster Populations.

Authors:  Mark A Phillips; Kenneth R Arnold; Zer Vue; Heather K Beasley; Edgar Garza-Lopez; Andrea G Marshall; Derrick J Morton; Melanie R McReynolds; Thomas T Barter; Antentor Hinton
Journal:  Int J Mol Sci       Date:  2022-01-19       Impact factor: 5.923

Review 5.  How to Slow down the Ticking Clock: Age-Associated Epigenetic Alterations and Related Interventions to Extend Life Span.

Authors:  Anne-Marie Galow; Shahaf Peleg
Journal:  Cells       Date:  2022-01-29       Impact factor: 6.600

6.  Association of Human Whole Blood NAD+ Contents With Aging.

Authors:  Fan Yang; Xuan Deng; Ye Yu; Lei Luo; Xianda Chen; Jinping Zheng; Yugang Qiu; Feng Xiao; Xiaomei Xie; Yuzheng Zhao; Jun Guo; Feifei Hu; Xuguang Zhang; Zhenyu Ju; Yong Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-21       Impact factor: 5.555

7.  Intravenous nicotinamide riboside elevates mouse skeletal muscle NAD+ without impacting respiratory capacity or insulin sensitivity.

Authors:  Mads V Damgaard; Thomas S Nielsen; Astrid L Basse; Sabina Chubanava; Kajetan Trost; Thomas Moritz; Ryan W Dellinger; Steen Larsen; Jonas T Treebak
Journal:  iScience       Date:  2022-02-02

8.  Sirtuin 7 Deficiency Reduces Inflammation and Tubular Damage Induced by an Episode of Acute Kidney Injury.

Authors:  Andrea Sánchez-Navarro; Miguel Ángel Martínez-Rojas; Adrián Albarrán-Godinez; Rosalba Pérez-Villalva; Johan Auwerx; Abigail de la Cruz; Lilia G Noriega; Florencia Rosetti; Norma A Bobadilla
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

Review 9.  NAD+ Precursors: A Questionable Redundancy.

Authors:  Carles Canto
Journal:  Metabolites       Date:  2022-07-09

Review 10.  Balancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations.

Authors:  Angelique Cercillieux; Eleonora Ciarlo; Carles Canto
Journal:  Cell Mol Life Sci       Date:  2022-08-02       Impact factor: 9.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.